BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14685699)

  • 1. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.
    Valen G
    Basic Res Cardiol; 2004 Jan; 99(1):1-7. PubMed ID: 14685699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
    Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor kappa-B and the heart.
    Valen G; Yan ZQ; Hansson GK
    J Am Coll Cardiol; 2001 Aug; 38(2):307-14. PubMed ID: 11499717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.
    Czibik G; Wu Z; Berne GP; Tarkka M; Vaage J; Laurikka J; Järvinen O; Valen G
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):976-84. PubMed ID: 18842422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
    Gu Q; Yang XP; Bonde P; DiPaula A; Fox-Talbot K; Becker LC
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):320-8. PubMed ID: 17204912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity and myocardial adaptation to ischemia.
    Valeur HS; Valen G
    Basic Res Cardiol; 2009 Jan; 104(1):22-32. PubMed ID: 18931966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats].
    Feng CS; Ma HC; Yue Y; Zhang YQ; Qu XD
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2110-4. PubMed ID: 15730629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFalpha in ischemia/reperfusion injury and heart failure.
    Schulz R; Aker S; Belosjorow S; Heusch G
    Basic Res Cardiol; 2004 Jan; 99(1):8-11. PubMed ID: 14685700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
    Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
    Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
    Kin H; Wang NP; Mykytenko J; Reeves J; Deneve J; Jiang R; Zatta AJ; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Shock; 2008 Jun; 29(6):761-8. PubMed ID: 18496137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
    Lecour S
    J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of apoptosis in reperfusion injury.
    Eefting F; Rensing B; Wigman J; Pannekoek WJ; Liu WM; Cramer MJ; Lips DJ; Doevendans PA
    Cardiovasc Res; 2004 Feb; 61(3):414-26. PubMed ID: 14962473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nuclear factor kappaB in cardiovascular health and disease.
    Van der Heiden K; Cuhlmann S; Luong le A; Zakkar M; Evans PC
    Clin Sci (Lond); 2010 Feb; 118(10):593-605. PubMed ID: 20175746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
    Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
    Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
    Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
    Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.